Please login to the form below

Not currently logged in
Email:
Password:

UCL

This page shows the latest UCL news and features for those working in and with pharma, biotech and healthcare.

Syncona start-up Quell Therapeutics appoints chief exec

Syncona start-up Quell Therapeutics appoints chief exec

With Syncona’s vision and the backing of leading experts in the Treg field, cell engineering, solid organ transplantation and autoimmune diseases from KCL, UCL and Hannover Medical School, Quell Therapeutics

Latest news

More from news
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    8.  Professor Kerry Chester, Antibody Engineering Group at UCL Cancer Institute. Kerry Chester is one of the UK’s foremost experts in antibody engineering, having over twenty years’ experience in the ... She works mainly in the translational field,

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    She established the MRC Clinical Trials Unit (CTU) at UCL as an internationally recognised centre of excellence for clinical trials, meta-analyses and epidemiological studies.

  • Behaviour Change Behaviour Change

    The Centre for Behaviour Change is a unique initiative, harnessing the breadth and depth of academic expertise in behaviour change at University College London (UCL) to address key challenges facing society ... is senior teaching fellow and Australasian

  • Should brand planning be a behaviour change challenge? Should brand planning be a behaviour change challenge?

    Michie and colleagues (2014) at the UCL Centre for Behaviour Change recently reviewed 83 theories of behaviour and behaviour change across multiple disciplines, and found that no one model was effective,

  • Evidence-based Adherence Strategies Evidence-based Adherence Strategies

    Professor Rob Horne, Professor of Behavioural Medicine, UCL, will start with understanding the real determinants of medicines-related behaviour and the findings of his 15-year research programme. ... We look forward to e-meeting you soon! Rob is

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics